Summary:
We are currently looking for study volunteers to participate in a clinical trial involving and investigational medication for Rheumatoid Arthritis. This clinical trial consists of 11 visits over a 12 week period. Compensation for time and travel is up to $600.
Qualified Participants Must:
• Be at least 18 years of age
•
Have a diagnosis of adult-onset RA for at least 6 months
•
Have moderately to severely active RA disease
•
Be on a dose of MTX between 12.5 to 25mg/week, which has been stable for at least 6 weeks prior to screening
•
Have had intolerance or inadequate response to treatment (ie, TNF-blocker failure) with no more than 2 licensed TNF-blocker therapies (etanercept, infliximab, golimumab, certolizumab pegol, or adalimumab) prior to study entry
•
Not have psoriatic arthritis, ankylosing spondylitis, gout, lupus, or Sjögren’s syndrome (primary or secondary)
•
Not have a history of Tuberculosis
Qualified Participants May Receive:
All study related procedures, supplies and medications at no cost and compensation for time and travel up to $600.